News Release


<< Back
INSYS Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference

PHOENIX, Jan. 03, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today that Saeed Motahari, president and chief executive officer, and Andy Long, chief financial officer, will present at the J.P. Morgan Healthcare Conference as follows:

   
Date:      Thursday, January 10th, 2019
Time:  10:30 a.m. Pacific Standard Time
Location: Westin St. Francis Hotel, San Francisco, California
   

The presentation will be webcast live at the above-mentioned time, and archived for 30 days thereafter, via the Investors section of company’s website at https://www.insysrx.com/, under Presentations & Events. Accessible at the same webpage, the presentation slides will be available during and after the conference.

About INSYS
INSYS Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients’ quality of life. Using proprietary spray technology and capabilities to develop pharmaceutical cannabinoids, INSYS is developing a pipeline of products intended to address unmet medical needs and the clinical shortcomings of existing commercial products. INSYS is committed to developing medications for potentially treating anaphylaxis, epilepsy, Prader-Willi syndrome, opioid addiction and overdose, and other disease areas with a significant unmet need.

   
CONTACT: Investor Relations & Corporate Communications
  Jackie Marcus or Chris Hodges
  Alpha IR Group
  312-445-2870
  INSY@alpha-ir.com

INSYS Logo.jpg

Source: INSYS Therapeutics, Inc.